Lesa Sroufe & Co’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$328K Hold
530
0.31% 49
2024
Q2
$293K Hold
530
0.28% 54
2024
Q1
$308K Hold
530
0.29% 53
2023
Q4
$281K Sell
530
-16
-3% -$7.75K 0.29% 55
2023
Q3
$276K Hold
546
0.3% 52
2023
Q2
$285K Hold
546
0.3% 57
2023
Q1
$315K Hold
546
0.32% 52
2022
Q4
$301K Hold
546
0.33% 53
2022
Q3
$277K Buy
+546
New +$306K 0.33% 55
2022
Q1
$317K Hold
546
0.32% 57
2021
Q4
$364K Sell
546
-100
-15% -$62.4K 0.37% 55
2021
Q3
$369K Hold
646
0.39% 54
2021
Q2
$326K Hold
646
0.32% 58
2021
Q1
$295K Hold
646
0.33% 54
2020
Q4
$301K Buy
646
+16
+3% +$7.5K 0.36% 54
2020
Q3
$278K Sell
630
-16
-2% -$6.61K 0.39% 53
2020
Q2
$234K Buy
+646
New +$217K 0.31% 55
2020
Q1
Sell
-646
Closed -$210K 64
2019
Q4
$210K Sell
646
-64
-9% -$19.4K 0.2% 60
2019
Q3
$207K Hold
710
0.2% 59
2019
Q2
$209K Buy
+710
New +$196K 0.18% 55

Other funds holding TMO

Lesa Sroufe & Co's TMO Position: Q3 2024 in Review

Lesa Sroufe & Co held its Thermo Fisher Scientific (TMO) position steady in Q3 2024 at 530 shares worth $328K. The position accounts for 0.31% of the portfolio, ranked #49.

Lesa Sroufe & Co first reported a position in TMO in Q2 2019 and has held it in 20 quarters since. The position peaked at $369K in Q3 2021. 2,569 funds tracked by Wall St. Rank hold TMO as of Q3 2024.

  • Lesa Sroufe & Co held 530 shares of Thermo Fisher Scientific worth $328K as of Q3 2024.
  • Lesa Sroufe & Co left its Thermo Fisher Scientific share count unchanged in Q3 2024.
  • Thermo Fisher Scientific made up 0.31% of Lesa Sroufe & Co's portfolio in Q3 2024, its #49 holding.
  • Lesa Sroufe & Co first reported a position in Thermo Fisher Scientific in Q2 2019 and has held it in 20 quarters since.
  • Lesa Sroufe & Co's Thermo Fisher Scientific position peaked at $369K in Q3 2021.
  • 2,569 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2024.

Based on Lesa Sroufe & Co's 13F filing for Q3 2024, filed 16 Oct 2024.